Genmab — Februar 2018
-
-
The 4 Best Biotech and Health Care Stocks to Buy for 2018 | Fortune
Turmoil over Obamacare hasn’t dimmed the outlook for most health care stocks.
Fortune (fortune.com)
-
When do we know more about the forecast for 18' and outlook for 19' ?
-
but here it is again http://www.4-traders.com/GENMAB-1412914/financials/
-
J&J and Theravance in $1-Billion Deal for Inflammatory Bowel Disease http://www.biopharminternational.com/jj-and-theravance-1-billion-deal-inflammatory-bowel-disease
-
Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma - http://onlinelibrary.wiley.com/doi/10.1111/bjh.15122/full
-
Jeg påtænker at starte i et medicinstudie bare for at følge med....min modne alder til trods....:-)
-
Hvor langt tror I den kommer ned inden 16:55
? Overvejer at købe lidt bullx4... -
Ud fra alle de fine links jeg ikke forstår en skid af må den jo stige i nærmeste fremtid

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind